A negative correlation of RBMS3 expression in the stromal cells with TNBC, and a positive one with ER- and PR-receptor status of the tumor, may indicate that there is a possibility for RBMS3 to display an antitumor effect depending on the molecular characteristics of the tumor. Here, RBMS3 is linked to neoplasm.